| |
|
|
|
Adial Pharmaceuticals Inc  
|
|
4.19 0.01 (0%) |
09-17 16:00 |
|
Open: |
4.21 |
Pre close: |
4.18 |
Target:
|
5.58
|
|
High: |
4.43 |
Low: |
4.13 |
Resistance:
|
4.78
5.58
|
|
Volume: |
445,156 |
Market Cap: |
86M |
Support:
|
3.68
 3.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.11
|
MACD |
MACD(12,26):
|
0.27  |
|
MA(20): |
4.04 |
Signal(12,26,9): |
0.32 |
|
MA(100): |
2.88 |
Stochastic Oscillator |
%K(14,3):
|
47.02 |
|
MA(250): |
2.43 |
%D(3): |
48.20 |
|
Average Volume(K) |
3-Month: |
86385
|
52-Week |
High:
|
4.78 |
|
10-Days: |
34382 |
Low: |
1.14 |
|
RSI |
RSI(14):
|
63.33 |
Change(%): |
227.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.973 |
Return on Equity (ttm) |
-236.1 |
Shares Out. (M) |
18.20 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-114.1 |
Shares Float (M) |
16.49 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.28 |
|
Forward EPS |
-0.870 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1090 |
|
Book Value (p.s.) |
0.320 |
EBITDA (p.s.) |
-0.879 |
P/E |
-4.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
13.09 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.87 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.76 |
P/CF |
-7.02 |
|
|
|
|
|
|
